Pancreatitis

Overview

Pancreatitis is inflammation of the pancreas, occurring in acute (AP) and chronic (CP) forms. Acute pancreatitis ranges from mild self-limiting disease to severe necrotizing pancreatitis with 20-30% mortality. Chronic pancreatitis is a risk factor for pancreatic cancer (relative risk 2.7-16x), making the pancreatitis→PDAC progression a clinically important trajectory where microbiome interventions may have preventive value.

Microbiome Associations

Acute Pancreatitis

  • Fungal dysbiosis is a feature of acute pancreatitis, with altered intestinal fungal communities detected early in the disease course [1].
  • Bacterial translocation from a dysbiotic gut is a major driver of secondary pancreatic infection in severe AP [2].
  • 16S rRNA sequencing of pancreatic infections identifies specific bacterial communities driving infectious complications [2].

Autoimmune Pancreatitis

Autoimmune pancreatitis (AIP) has a distinct fecal microbiota compared to pancreatic ductal adenocarcinoma (PDAC), despite overlapping clinical presentations. Shotgun metagenomics revealed differential functional profiles that may serve as diagnostic biomarkers [3].

Causal Evidence

mendelian randomization supports a causal relationship between specific gut microbiota and pancreatitis risk [4].

Interventions

Probiotics/Prebiotics/Synbiotics in Severe AP

Meta-analysis of 13 RCTs found that probiotics, prebiotics, and synbiotics reduce infectious complications in severe acute pancreatitis [5]. The mechanism likely involves:

  • Strengthening gut barrier integrity to prevent bacterial translocation
  • Modulating immune response to reduce pancreatic necrosis infection
  • Competing with pathobionts for intestinal niches

Pancreatitis-to-Pancreatic Cancer Progression

Chronic pancreatitis is the strongest non-genetic risk factor for pancreatic cancer. The microbiome changes in CP may create a pro-tumorigenic environment through:

  • Chronic inflammation via tlr4/NF-kB activation
  • Altered bile acid metabolism affecting immune surveillance
  • Mycobiome dysbiosis persisting through the progression

Cross-References

References (5)

  1. Meng-Qi Zhao, Miao-Yan Fan, Meng-Yan Cui et al. (2025). Profile of intestinal fungal microbiota in acute pancreatitis patients and healthy individuals. Gut Pathogens. doi:10.1186/s13099-024-00675-z
  2. Ning Sun, Yong Chen, Jiaxun Zhang et al. (2023). Identification and characterization of pancreatic infections in severe and critical acute pancreatitis patients using 16S rRNA gene next generation sequencing. Frontiers in Microbiology. doi:10.3389/fmicb.2023.1185216
  3. Wenli Zhou, De Zhang, Zhengpeng Li et al. (2021). The fecal microbiota of patients with pancreatic ductal adenocarcinoma and autoimmune pancreatitis characterized by metagenomic sequencing. Journal of Translational Medicine. doi:10.1186/s12967-021-02882-7
  4. Kui Wang, Xianzheng Qin, Taojing Ran et al. (2023). Causal link between gut microbiota and four types of pancreatitis: a genetic association and bidirectional Mendelian randomization study. Frontiers in Microbiology. doi:10.3389/fmicb.2023.1290202
  5. Xu Tian, Yuan-Ping Pi, Xiao-Ling Liu et al. (2018). Supplemented Use of Pre-, Pro-, and Synbiotics in Severe Acute Pancreatitis: An Updated Systematic Review and Meta-Analysis of 13 Randomized Controlled Trials. Frontiers in Pharmacology. doi:10.3389/fphar.2018.00690

Related Articles